Hakan Erdem

Hakan Erdem

Auto-generated profile, based on publicly available information

Hakan Erdem

Clinics of Rheumatology Department, Medicana International Ankara Hospital, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2026 in Bratislava Medical Journal
Verified
Journal Article
Open access
PDF file
YSYasemin Soysal
Yasemin Soysal
MÇMuhammet Çınar
Muhammet Çınar
NSNAZLI SENSOY
NAZLI SENSOY
FIfadime mutlu icduygu
fadime mutlu icduygu
SYSedat YILMAZ
Sedat YILMAZ
HEHakan Erdem
Hakan Erdem
Objective: The inflammatory process resulting from the autoimmune response has a fundamental role in the pathogenesis of ankylosing spondylitis (AS). The PDCD1 gene regulates the immune system and may play a role in the pathogenesis of autoimmune diseases. In this study, we aimed to investigate the role of single-nucleotide polymorphisms (SNPs) within the PDCD1 gene and their corresponding haplotypes as potential biomarkers for susceptibility to AS in Turkish patients. Materials and Methods: A total of 150 AS patients and 144 healthy individuals were examined for the genotypes of PD-1.1, PD-1.3, PD-1.5, and PD-1.9 SNPs using the method of PCR–RFLP from peripheral blood DNA extracts. Results: Regarding the genotype frequencies of PD-1.1 ( p = 0.952), PD-1.3 ( p = 0.106), PD-1.5 ( p = 0.653), and PD-1.9 ( p = 0.994) polymorphisms, no significant difference was found between patients with AS and controls. Conclusion: The PDCD1 gene plays a crucial role in the T cell activation’s negative regulation of peripheral tolerance. Population-based differences have been reported in the PDCD1 gene polymorphism. Our study presents data on PDCD1 gene polymorphism for the first time in a Turkish cohort of ankylosing spondylitis patients and discusses the role of this gene as a biomarker for AS disease pathogenesis.